A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Celgene
Istari Oncology, Inc.
Y-mAbs Therapeutics
Bristol-Myers Squibb
Novartis
INSYS Therapeutics Inc
Pfizer
Eli Lilly and Company